Malignant Primary Gliomas
3 clinical trials · Condition
◉ Watch Malignant Primary Gliomas
| Record | Firm | Date |
|---|---|---|
| 5G-PEARL: Paxalisib in Malignant Brain Tumours (NCT07391215) | Institute of Cancer Research, United Kingdom | 2026-01-19 |
| 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours (NCT06630260) | Institute of Cancer Research, United Kingdom | 2024-11-15 |
| 5G-EMERALD: Amivantamab in Malignant Brain Tumours (NCT06632236) | Institute of Cancer Research, United Kingdom | 2024-10-09 |
Track Malignant Primary Gliomas automatically
Every clearance here is in the API, with alerts when new ones post.